|
Quotes & Info
|
| REGN > SEC Filings for REGN > Form 8-K on 14-Feb-2013 | All Recent SEC Filings |
14-Feb-2013
Results of Operations and Financial Condition, Financial Statements
On February 14, 2013, Regeneron Pharmaceuticals, Inc. issued a press release announcing its financial and operating results for the quarter and year ended December 31, 2012. The press release is being furnished to the Securities and Exchange Commission pursuant to Item 2.02 of Form 8-K and is attached as Exhibit 99.1 to this Form 8-K.
(d) Exhibits
99.1 Press Release dated February 14, 2013.
|
|